S. Argyropoulos

1.0k total citations
15 papers, 751 citations indexed

About

S. Argyropoulos is a scholar working on Experimental and Cognitive Psychology, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, S. Argyropoulos has authored 15 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Experimental and Cognitive Psychology, 5 papers in Cognitive Neuroscience and 2 papers in Molecular Biology. Recurrent topics in S. Argyropoulos's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers), Mental Health Research Topics (4 papers) and Stress Responses and Cortisol (2 papers). S. Argyropoulos is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers), Mental Health Research Topics (4 papers) and Stress Responses and Cortisol (2 papers). S. Argyropoulos collaborates with scholars based in United Kingdom, Australia and Germany. S. Argyropoulos's co-authors include David Nutt, D.J. Nutt, DJ NUTT, SJ Wilson, David S. Baldwin, TC Britton, C. Idzikowski, Colin A. Espie, Derk‐Jan Dijk and Ann L. Sharpley and has published in prestigious journals such as Psychopharmacology, Acta Psychiatrica Scandinavica and Journal of Psychopharmacology.

In The Last Decade

S. Argyropoulos

15 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Argyropoulos United Kingdom 10 465 376 181 119 84 15 751
DJ NUTT United Kingdom 9 451 1.0× 354 0.9× 175 1.0× 105 0.9× 97 1.2× 14 769
G. Hajak Germany 13 571 1.2× 744 2.0× 217 1.2× 182 1.5× 44 0.5× 37 1.2k
C. Idzikowski United Kingdom 17 682 1.5× 697 1.9× 265 1.5× 159 1.3× 193 2.3× 33 1.2k
Ann Rich United Kingdom 11 279 0.6× 165 0.4× 63 0.3× 50 0.4× 81 1.0× 18 524
Jeanine Kamphuis Netherlands 16 423 0.9× 301 0.8× 154 0.9× 167 1.4× 121 1.4× 36 1.0k
F. Picarel-Blanchot France 14 231 0.5× 225 0.6× 212 1.2× 130 1.1× 51 0.6× 28 872
Gloria Arankowsky‐Sandoval Mexico 18 187 0.4× 312 0.8× 129 0.7× 55 0.5× 207 2.5× 39 748
Judy Caron United States 11 982 2.1× 843 2.2× 460 2.5× 133 1.1× 60 0.7× 14 1.2k
Horst Gann Germany 18 389 0.8× 458 1.2× 115 0.6× 126 1.1× 186 2.2× 35 879
Jon Nash United Kingdom 11 347 0.7× 209 0.6× 69 0.4× 73 0.6× 125 1.5× 18 654

Countries citing papers authored by S. Argyropoulos

Since Specialization
Citations

This map shows the geographic impact of S. Argyropoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Argyropoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Argyropoulos more than expected).

Fields of papers citing papers by S. Argyropoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Argyropoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Argyropoulos. The network helps show where S. Argyropoulos may publish in the future.

Co-authorship network of co-authors of S. Argyropoulos

This figure shows the co-authorship network connecting the top 25 collaborators of S. Argyropoulos. A scholar is included among the top collaborators of S. Argyropoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Argyropoulos. S. Argyropoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hood, Sean, et al.. (2016). Don’t panic. A guide to tryptophan depletion with disorder-specific anxiety provocation. Journal of Psychopharmacology. 30(11). 1137–1140. 5 indexed citations
2.
Wilson, SJ, DJ NUTT, Chris Alford, et al.. (2010). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. Journal of Psychopharmacology. 24(11). 1577–1601. 467 indexed citations
3.
Almeida, Susana, David C. Glahn, S. Argyropoulos, & Sophia Frangou. (2009). Acute citalopram administration may disrupt contextual information processing in healthy males. European Psychiatry. 25(2). 87–91. 12 indexed citations
4.
Argyropoulos, S., Sabine Landau, Sridevi Kalidindi, et al.. (2008). Twins discordant for schizophrenia: psychopathology of the non‐schizophrenic co‐twins. Acta Psychiatrica Scandinavica. 118(3). 214–219. 17 indexed citations
5.
Hood, Sean, Simon Davies, Dana Hince, et al.. (2008). Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants. Journal of Psychopharmacology. 24(5). 709–716. 16 indexed citations
6.
Plainis, Sotiris, et al.. (2008). Threat and anxiety affect visual contrast perception. Journal of Psychopharmacology. 24(5). 667–675. 13 indexed citations
7.
Argyropoulos, S., Sean Hood, Simon Davies, et al.. (2006). S.15.04 Dopaminergic challenges in social anxiety disorder. European Neuropsychopharmacology. 16. S186–S186. 1 indexed citations
8.
Pyle, Angela, S. Argyropoulos, & David Nutt. (2004). The role of serotonin in panic: evidence from tryptophan depletion studies. Acta Neuropsychiatrica. 16(2). 79–84. 2 indexed citations
9.
Nash, Jon, et al.. (2004). P3.044 Alttered 5HT1A binding in panic disorderdemonstrated by positron emission tomography. European Neuropsychopharmacology. 14. S322–S323. 6 indexed citations
10.
Bailey, Jayne, S. Argyropoulos, Stafford L. Lightman, & D.J. Nutt. (2003). Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?. Journal of Psychopharmacology. 17(3). 252–259. 73 indexed citations
11.
Bailey, Jayne, S. Argyropoulos, Stafford L. Lightman, & D.J. Nutt. (2003). Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge? Reply to Reviewers' Comments. Journal of Psychopharmacology. 17(3). 267–268. 4 indexed citations
12.
Sandford, John, et al.. (2001). Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder. Journal of Psychopharmacology. 15(3). 205–208. 19 indexed citations
13.
Argyropoulos, S. & David Nutt. (2000). Substance P antagonists: novel agents in the treatment of depression. Expert Opinion on Investigational Drugs. 9(8). 1871–1875. 27 indexed citations
14.
Argyropoulos, S. & David Nutt. (1999). The use of benzodiazepines in anxiety and other disorders. European Neuropsychopharmacology. 9. S407–S412. 70 indexed citations
15.
Argyropoulos, S. & D.J. Nutt. (1997). Anhedonia and chronic mild stress model in depression. Psychopharmacology. 134(4). 333–336. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026